Milestone Scientific (MLSS) Competitors $0.99 -0.09 (-8.33%) Closing price 04:00 PM EasternExtended Trading$1.01 +0.02 (+2.53%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock MLSS vs. SMTI, LUNG, RCEL, NVRO, ELMD, PROF, LAKE, INGN, DRTS, and AVRShould you be buying Milestone Scientific stock or one of its competitors? The main competitors of Milestone Scientific include Sanara MedTech (SMTI), Pulmonx (LUNG), AVITA Medical (RCEL), Nevro (NVRO), Electromed (ELMD), Profound Medical (PROF), Lakeland Industries (LAKE), Inogen (INGN), Alpha Tau Medical (DRTS), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. Milestone Scientific vs. Sanara MedTech Pulmonx AVITA Medical Nevro Electromed Profound Medical Lakeland Industries Inogen Alpha Tau Medical Anteris Technologies Global Sanara MedTech (NASDAQ:SMTI) and Milestone Scientific (NYSE:MLSS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment. Does the MarketBeat Community believe in SMTI or MLSS? Sanara MedTech received 21 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 60.53% of users gave Sanara MedTech an outperform vote while only 2.35% of users gave Milestone Scientific an outperform vote. CompanyUnderperformOutperformSanara MedTechOutperform Votes2360.53% Underperform Votes1539.47% Milestone ScientificOutperform Votes22.35%Underperform Votes8397.65% Do institutionals and insiders believe in SMTI or MLSS? 8.1% of Sanara MedTech shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 54.1% of Sanara MedTech shares are held by insiders. Comparatively, 24.8% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts rate SMTI or MLSS? Sanara MedTech presently has a consensus target price of $48.50, indicating a potential upside of 60.70%. Milestone Scientific has a consensus target price of $1.25, indicating a potential upside of 22.55%. Given Sanara MedTech's higher probable upside, equities analysts plainly believe Sanara MedTech is more favorable than Milestone Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sanara MedTech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, SMTI or MLSS? Sanara MedTech has higher revenue and earnings than Milestone Scientific. Sanara MedTech is trading at a lower price-to-earnings ratio than Milestone Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSanara MedTech$78.06M3.38-$4.30M-$0.99-30.48Milestone Scientific$8.88M8.95-$6.93M-$0.07-14.57 Is SMTI or MLSS more profitable? Sanara MedTech has a net margin of -10.71% compared to Milestone Scientific's net margin of -52.01%. Sanara MedTech's return on equity of -19.86% beat Milestone Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Sanara MedTech-10.71% -19.86% -10.91% Milestone Scientific -52.01%-60.26%-40.23% Which has more risk and volatility, SMTI or MLSS? Sanara MedTech has a beta of 1.37, indicating that its stock price is 37% more volatile than the S&P 500. Comparatively, Milestone Scientific has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Does the media prefer SMTI or MLSS? In the previous week, Sanara MedTech had 17 more articles in the media than Milestone Scientific. MarketBeat recorded 18 mentions for Sanara MedTech and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.59 beat Sanara MedTech's score of 0.52 indicating that Milestone Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sanara MedTech 2 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Milestone Scientific 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySanara MedTech beats Milestone Scientific on 12 of the 17 factors compared between the two stocks. Remove Ads Get Milestone Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MLSS vs. The Competition Export to ExcelMetricMilestone ScientificSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$79.45M$8.80B$5.64B$19.32BDividend YieldN/A1.42%4.57%3.75%P/E Ratio-14.5717.2223.1332.90Price / Sales8.9565.51388.4726.44Price / CashN/A19.6738.1617.54Price / Book9.275.416.884.52Net Income-$6.93M$284.66M$3.20B$1.02B7 Day Performance0.99%-2.80%-2.80%-1.41%1 Month Performance8.52%-5.51%1.74%-4.15%1 Year Performance63.72%-21.08%9.80%3.29% Milestone Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MLSSMilestone Scientific0.9892 of 5 stars$0.99-8.3%$1.25+26.3%+71.6%$77.11M$8.88M-14.1430SMTISanara MedTech2.3073 of 5 stars$35.69+6.2%$47.00+31.7%-16.3%$311.97M$78.06M-36.0560Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageLUNGPulmonx3.1815 of 5 stars$7.37-5.1%$13.36+81.2%-25.5%$293.30M$83.79M-5.12250RCELAVITA Medical1.6283 of 5 stars$9.32+4.0%$17.25+85.1%-44.1%$244.35M$64.25M-3.90130Short Interest ↑NVRONevro0.8922 of 5 stars$5.79+0.3%$6.43+11.1%-59.5%$221.98M$408.52M-3.061,215ELMDElectromed1.0968 of 5 stars$24.45-1.1%$38.00+55.4%+45.5%$209.22M$59.63M32.60160Analyst DowngradePROFProfound Medical2.1784 of 5 stars$6.81flat$14.25+109.3%-25.2%$204.57M$10.68M-5.08150LAKELakeland Industries4.7978 of 5 stars$21.09+12.4%$28.33+34.3%+25.4%$200.33M$151.82M-234.331,800Analyst UpgradeNews CoverageHigh Trading VolumeINGNInogen2.9402 of 5 stars$7.37+0.3%$7.00-5.0%-10.4%$195.53M$335.71M-3.281,030DRTSAlpha Tau Medical1.8641 of 5 stars$2.70+3.4%$8.00+196.3%-9.8%$188.80MN/A-6.2880Short Interest ↑AVRAnteris Technologies GlobalN/A$5.12-1.2%$16.50+222.3%N/A$184.44M$2.71M0.00138News CoverageHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Sanara MedTech Alternatives Pulmonx Alternatives AVITA Medical Alternatives Nevro Alternatives Electromed Alternatives Profound Medical Alternatives Lakeland Industries Alternatives Inogen Alternatives Alpha Tau Medical Alternatives Anteris Technologies Global Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MLSS) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Milestone Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
